30-Jan-2006 - A new way of producing antibodies with increased cancer-killing ability has been developed by researchers at Dartmouth's Thayer School of Engineering, the Dartmouth Medical School, and the biotech firm GlycoFi.
30-Jan-2006 - Sirna Therapeutics has been granted a US patent covering a more efficient process for the chemical synthesis and manufacturing of GMP-quality ribonucleic acids (RNA), for use in RNA-based drugs.
16-Jan-2006 - Biotage has acquired exclusive rights to an evaporation technology, which substantially reduces sample-drying time for pharmaceutical chemists, meeting the need to relieve a major bottleneck in chemistry and drug development.
23-Dec-2005 - Crucell and DSM will further expand the development of its PER.C6 protein and monoclonal antibody licensing business by establishing joint R&D centres on the US East Coast and in the Netherlands.
14-Dec-2005 - GlaxoSmithKline (GSK) has positioned itself to dominate the US flu vaccine market after it completed the acquisition of Canadian vaccine company ID Biomedical for $1.7 billion (€1.15 billion) last week.
31-Oct-2005 - GE Healthcare has recently launched a number of diverse and transformational medical technologies aimed at improving productivity across the pharmaceutical manufacturing sector.
24-Oct-2005 - Novasep Process launches its latest Supercritical Fluid Chromatography unit, which aims to cut time and operating costs by incorporating an automated CO2 recycling feature making it suitable for purification process development, laboratory and turn-key industrial solutions.
24-Oct-2005 - In response to the increasing demand for high potency APIs, Omnichem is increasing its Class V handling capabilities with an expansion of their facility in Louvain-la-Neuve, Belgium.
12-Oct-2005 - Freeman Technology introduces its new aeration control unit for its FT4 Powder Rheometer, which allows airflow control through a powder under test, enabling the automated measurement of the powder's flow properties.
06-Oct-2005 - Sweden's Biotage, a specialist in microwave synthesis and chromatography systems for drug development and production, has taken some of its European distribution into its own hands through the purchase of Separtis Holding.
06-Oct-2005 - The pharmaceutical division of French packaging company Valois has completed construction of a pilot filling and packaging unit based at its site in Le Vaudreuil in the Eure area of France, dedicated to the production of pressurised medicinal preparations for administration via the pulmonary route.
05-Oct-2005 - Codexis has achieved a second technical milestone, earlier than expected, in a collaboration with Pfizer aimed at developing new biocatalysts for the manufacture of the number one drugmaker's products.
04-Oct-2005 - Researchers in France have developed a new microporous material that could have a range of applications for the pharmaceutical industry, including chemical separation and catalysis in medicine manufacturing and drug delivery.
03-Oct-2005 - Innovata of the UK has sold off its gene expression technology UCOE to Celliance Corp, a wholly owned subsidiary of Serologicals, for an undisclosed fee.
03-Oct-2005 - CEM Corp has announced the formation of a division within the company that will be focused on developing systems for scaling up reactions performed using microwave synthesis.
28-Sep-2005 - Greenbridge Environmental Control of the UK has introdueced a new cleaner and disinfectant agent, suitable for commercial scale applications, that is claimed to be the first non-toxic product of its type.
20-Sep-2005 - Key Technology has set up a dedicated pharmaceutical business unit, Symetix, to lend some focus to its efforts to sell automated inspection and specialised conveying systems to the drug industry.
16-Sep-2005 - UK pharmaceutical testing company Cirrus Laboratories has been acquired by Bodycote Materials Testing, an international provider of materials testing services to industry.
14-Sep-2005 - Novavax and Wave Biotech are to collaborate on the development of a commercial scale production process for the former's pandemic influenza virus vaccine and other biological products.
12-Sep-2005 - Separations specialist Whatman is starting to reap the benefits of its acquisition of Schleicher & Schuell, but had a difficult first half to the year with the group's combined revenues down marginally compared to first-half 2004.
07-Sep-2005 - A suite of optical detection methods, developed by Finnish researchers alongside world number two drugmaker GlaxoSmithKline, promises to cut the cost of drug production and increase the safety and quality of medicinal products.
05-Sep-2005 - Malvern has launched a new generation Spraytec system for particle size analysis of aerosols and sprays.
25-Aug-2005 - Researchers at Rensselaer Polytechnic Institute in the US have developed a method to predict protein separation behaviour - directly from protein structure - that could reduce the time it takes to bring pharmaceuticals to market.
25-Aug-2005 - In the US, Altor BioScience has received a phase I Small Business Innovation Research (SBIR) grant from the National Cancer Institute (NCI) to support development of its processes for making therapeutic antibodies in transgenic lettuce.
17-Aug-2005 - Germany's Bruker AXS is to acquire privately held French company Socabim, a company focused on advanced X-ray materials research and analysis software.